Scinai Immunotherapeutics...

NASDAQ: SCNI · Real-Time Price · USD
1.73
0.20 (12.70%)
At close: Aug 21, 2025, 3:59 PM
1.68
-2.89%
After-hours: Aug 21, 2025, 07:59 PM EDT

Scinai Immunotherapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
582.96K 206K 168K 284K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a 373K 417K 448K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a -167K -249K -164K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-1.2M -2.26M -2.42M 3.96M -2.05M -1.82M -2.1M 8.97M -3.19M 4.32M 1.08M -3.26M -2.62M 7.68M -2.55M -2.73M -2.02M
Interest Income
10.94K n/a 14.76M n/a 2.56K n/a 5.19M n/a n/a n/a 1.78M 469.03K 378.94K 923.84K 612.26K n/a 370.35K
Pretax Income
n/a -2.2M 10.46M -2.32M -2.16M -2.33M 3.11M -3.76M -3.52M -529K 1.05M -2.98M -2.48M 1.19M -2.81M -3.68M -2.45M
Net Income
-1.55M -2.23M 10.46M -2.32M -2.16M -2.33M 3.11M -3.76M -3.52M -529K 1.05M -2.98M -2.48M 1.19M -2.81M -3.68M -2.45M
Selling & General & Admin
497.4K 759K 764K 519K 484K 1.13M 968K 1.14M 1.19M 1.81M 937.21K 1.29M 1.45M 2.09M 1.92M 2.15M 1.2M
Research & Development
1.29M 1.34M 1.41M 1.22M 1.58M 627K 1.13M 1.45M 2M 1.74M 1.12M 1.97M 1.37M 1.1M 627.77K 582.73K 822.42K
Other Expenses
n/a n/a n/a 572K -124K -9K n/a -11.55M n/a -7.88M -3.14M n/a -209K -10.87M n/a n/a n/a
Operating Expenses
1.79M 2.1M 2.17M -4.12M 1.93M 1.82M 2.1M -8.97M 3.19M -4.32M -1.08M 3.26M 2.62M -7.68M 2.55M 2.73M 2.02M
Interest Expense
10.94K 37K 1.88M 293.92K 233.56K 512.5K n/a 1.15M 325.92K n/a 1.81M 189.03K 238.94K 863.29K 866.13K 837.19K 798.31K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
-1.79M 2.47M 2.59M -3.67M 2.05M 1.82M 2.1M -8.97M 3.19M -4.32M -1.08M 3.26M 2.62M -7.68M 2.55M 2.73M 2.02M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
806.37K 392.23K 843.57K 637.6K 506.54K 223.32K 469.22K 337.96K 292.92K 194.35K 186.79K 186.72K 186.18K 75.06K 113.07K 143.3K 132.71K
Shares Outstanding (Diluted)
806.37K 1.24M 843.57K 637.6K 506.54K 300.38K 469.22K 337.96K 323.81K 194.35K 186.79K 186.72K 186.18K 145.15K 143.3K 143.3K 132.71K
EPS (Basic)
-1.19 -22.76K 49.56K -14.56K -17.04K -31.04K 26.48K -44.52K -43.4K -10.88K 22.52K -63.92K -53.16K 32.8K -78.32K -102.68K -73.8K
EPS (Diluted)
-1.19 -22.76K 49.56K -14.56K -17.04K -41.72K 26.48K -44.52K -48K -46.8K 22.52K -63.92K -53.16K -63.44K -99.24K -102.68K -73.8K
EBITDA
-1.19M -1.67M 10.99M -1.53M -1.77M -1.74M -1.96M -2.45M -3.05M -6.6M 1.3M -3.12M -2.48M -3.06M -2.36M -2.54M -1.84M
EBIT
-1.19M -2.26M 12.34M -2.03M -1.93M -1.82M -2.1M -2.6M -3.19M -6.74M 1.08M -3.26M -2.62M -3.18M -2.55M -2.73M -2.02M
Depreciation & Amortization
n/a 499K 498K 496K 156K 84K 145K 145.33K 138K 140.5K 218.18K 145K 134K 188.32K 189.82K 185.16K 184.84K